Laura Sargent
About Laura Sargent
Laura Sargent is the Associate Director of New Product Planning at Alkermes, with a background in virology and extensive experience in strategic planning and competitive analysis within the pharmaceutical industry.
Title and Current Role
Laura Sargent is currently serving as the Associate Director of New Product Planning at Alkermes. In this role, she participates in cross-functional teams to drive new product initiatives, leveraging her expertise in both scientific research and business strategy.
Professional Experience
Laura Sargent has amassed a wealth of experience in new product planning and competitive analysis across several notable pharmaceutical companies. She served as Senior Manager of New Product Planning at Cyclerion from 2019 to 2021, and held a similar position at Ironwood Pharmaceuticals in 2019. Prior to that, she worked at Takeda Oncology from 2016 to 2019, where she contributed to strategic planning for oncology products. Her earlier roles include a postdoctoral fellowship in corporate strategy at Biogen from 2014 to 2016.
Education and Expertise
Laura Sargent earned a Doctor of Philosophy (PhD) in Virology from Harvard Medical School, where she studied from 2008 to 2014. She also holds a Bachelor's degree (ScB) in Biology from Brown University. Additionally, she achieved a CORe Credential of Readiness from HBX at Harvard Business School. Her academic background is complemented by her experience conducting and presenting research, as well as authoring several peer-reviewed publications in virology.
Research and Publications
During her PhD at Harvard Medical School, Laura authored multiple peer-reviewed publications in the field of virology. She also presented her research findings at international virology conferences. She received the Research in Science and Engineering Scholarship from the DAAD German Academic Exchange Service in 2006, which involved conducting research at the University of Bayreuth.
Mentorship and Leadership
Laura Sargent has demonstrated strong mentorship and leadership skills throughout her career. She has mentored junior scientists and analysts during her time at Biogen and Takeda Oncology. Her ability to bridge the gap between R&D and commercial teams has been a significant factor in her roles, particularly in the strategic and launch planning of new pharmaceutical products.